Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01604330Phase 2Completed

Baclofen for the Treatment of Alcohol Drinkers

Role: collaborator

NCT01279278Not ApplicableUnknown

Does the Invitation by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening?

Role: collaborator

NCT01279330Not ApplicableUnknown

Does the Recall by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening?

Role: collaborator

NCT00398944Not ApplicableCompleted

Impact of a Computerized Guidelines on the Management of Hypertension and Diabetes

Role: lead

All 4 trials loaded